These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2525955)

  • 1. Left ventricular dilatation following myocardial infarction: clinical course and potential for therapy.
    Lamas GA
    Cardiology; 1989; 76(2):112-21. PubMed ID: 2525955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular remodeling after acute myocardial infarction: clinical course and beneficial effects of angiotensin-converting enzyme inhibition.
    Lamas GA; Pfeffer MA
    Am Heart J; 1991 Apr; 121(4 Pt 1):1194-202. PubMed ID: 1826184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.
    Pfeffer MA; Lamas GA; Vaughan DE; Parisi AF; Braunwald E
    N Engl J Med; 1988 Jul; 319(2):80-6. PubMed ID: 2967917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
    Pfeffer MA; Braunwald E
    Circulation; 1990 Apr; 81(4):1161-72. PubMed ID: 2138525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
    Pfeffer MA; Braunwald E; Moyé LA; Basta L; Brown EJ; Cuddy TE; Davis BR; Geltman EM; Goldman S; Flaker GC
    N Engl J Med; 1992 Sep; 327(10):669-77. PubMed ID: 1386652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular enlargement and reduced survival after myocardial infarction.
    Pfeffer MA; Pfeffer JM
    Circulation; 1987 May; 75(5 Pt 2):IV93-7. PubMed ID: 2952370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive ventricular dilation in experimental myocardial infarction and its attenuation by angiotensin-converting enzyme inhibition.
    Pfeffer JM
    Am J Cardiol; 1991 Nov; 68(14):17D-25D. PubMed ID: 1836094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.
    Rutherford JD; Pfeffer MA; Moyé LA; Davis BR; Flaker GC; Kowey PR; Lamas GA; Miller HS; Packer M; Rouleau JL
    Circulation; 1994 Oct; 90(4):1731-8. PubMed ID: 7923656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape.
    Mitchell GF; Lamas GA; Vaughan DE; Pfeffer MA
    J Am Coll Cardiol; 1992 May; 19(6):1136-44. PubMed ID: 1532970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.
    St John Sutton M; Pfeffer MA; Moye L; Plappert T; Rouleau JL; Lamas G; Rouleau J; Parker JO; Arnold MO; Sussex B; Braunwald E
    Circulation; 1997 Nov; 96(10):3294-9. PubMed ID: 9396419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
    Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular dilatation and remodeling after myocardial infarction.
    Rumberger JA
    Mayo Clin Proc; 1994 Jul; 69(7):664-74. PubMed ID: 8015331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmyocardial infarction patients: experience from the SAVE trial.
    Connors KF; Lamas GA
    Am J Crit Care; 1995 Jan; 4(1):23-8. PubMed ID: 7894551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expansion and remodelling of the left ventricle after myocardial infarction].
    Gallet B; Hiltgen M
    Ann Cardiol Angeiol (Paris); 1990 Nov; 39(9):541-6. PubMed ID: 2149811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE Investigators.
    Moyé LA; Pfeffer MA; Braunwald E
    Am J Cardiol; 1991 Nov; 68(14):70D-79D. PubMed ID: 1836100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the tissue affinity of ACE inhibitors of relevance for the remodeling of the left ventricular wall following myocardial infarction? Estimations with cine magnetic resonance imaging.
    Konermann M; Sanner BM; Altmann C; Laschewski F; Rawert B; Trappe HJ
    Cardiology; 2000; 94(3):179-87. PubMed ID: 11279324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction.
    Jugdutt BI; Lucas A; Khan MI
    Can J Cardiol; 1997 Jul; 13(7):657-68. PubMed ID: 9251578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early preventive treatment of left ventricular dysfunction following myocardial infarction: optimal timing and patient selection.
    Sharpe N
    Am J Cardiol; 1991 Nov; 68(14):64D-69D. PubMed ID: 1836098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.